Yunmeng county in Central China's Hubei taps into rich cultural relics to develop cultural tourism
BEIJING,Nov. 9,2024-- A report from People\'s Daily:Yunmeng county in central China\'s Hubei province is leveraging its rich historical and cultural resources to boost the development of cultural tour
Shanghai Electric signed new memoranda of cooperation and strategic agreements with Carrier Group and Svenska Kullagerfabriken AB (SKF) China Sales Co.,Ltd. at CIIE 2024
KOTA KINABALU,Malaysia,Nov. 4,2024-- Futurise Sdn Bhd (Futurise),in collaboration with the Sabah Economic Development and Investment Authority (SEDIA) and the National Academy of Drone Sports Excellen
Toshiba's Commitment to a Quantum-Safe Singapore
SINGAPORE,Nov. 5,2024-- As a global business hub with advanced digital connectivity,Singapore is well-positioned to lead the charge in quantum-safe technologies. The 2023 Singapore Digital Connectivi
The Zunyi Talk "China's Development: An Opportunity for a Colorful World" Successfully Held
ZUNYI,China,Nov. 3,2024-- On October 31,theZunyi Talk "China\'s Development: An Opportunity for a Colorful World" was held in Zunyi City,southwest China\'s Guizhou Province. The event was at
2024 Global Forum on Hehe Culture held in Taizhou
TAIZHOU,China,Nov. 3,2024-- This is a report from China SCIO. The 2024 Global Forum on Hehe Culture with the theme of "Hehe Culture and New Model for Human Progress" was held in Tiantai coun
HONG KONG and SHANGHAI,Nov. 3,2024-- October 29,2024, Ping An Healthcare Technology Co.,Ltd. successfully obtained the Digital Health Certificate (DHC) from the World Organization of Family Doctors (W
REPT Secures Spot on BNEF's Global Tier 1 List for Fourth Consecutive Quarter
IRVINE,Calif.,Nov. 4,2024-- BloombergNEF (BNEF) has released its Q4 2024 Global Tier 1 Energy Storage Manufacturers list,recognizing REPT Battero Energy Co.,Ltd. (REPT) once again been for its technol
Blackpanda and CSA will exchange intelligence to enhance their capabilities against cyber threats CSA joins Blackpanda\'s network of esteemed partners in Singapore,including Singtel and the Singapore
CHENGDU,China,Oct. 31,2024-- The new drug application (NDA) (the "Application") based on the positive results from the pivotalphase III OptiTROP-Lung04 study of sacituzumab tirumotecan (sac-